Finny Kuruvilla, MD, PhD
Finny Kuruvilla, MD, PhD joined Clarus Ventures from the Broad Institute of Harvard and MIT where he led a collaborative effort with Affymetrix (NASDAQ: AFFX) in medical and population genetics.
Previously, he completed his residency and fellowship at the Brigham & Women’s Hospital and Children’s Hospital Boston where he cared for adult and pediatric patients suffering from a variety of hematologic, oncologic, and autoimmune disorders. He received his M.D. from Harvard Medical School, his Ph.D. in chemistry and chemical biology from Harvard University, his master’s degree in electrical engineering and computer science from MIT, and his bachelor’s degree in chemistry from Caltech.